| The C-terminal domain of RNA polymerase II is modified by site-specific methylation RJ Sims III, LA Rojas, D Beck, R Bonasio, R Schüller, WJ Drury III, D Eick, ... Science 332 (6025), 99-103, 2011 | 261 | 2011 |
| Crystal structure of TDRD3 and methyl-arginine binding characterization of TDRD3, SMN and SPF30 K Liu, Y Guo, H Liu, C Bian, R Lam, Y Liu, F Mackenzie, LA Rojas, ... PloS one 7 (2), e30375, 2012 | 103 | 2012 |
| A diagnostic oligonucleotide microarray for simultaneous detection of grapevine viruses EA Engel, PF Escobar, LA Rojas, PA Rivera, N Fiore, PDT Valenzuela Journal of Virological Methods 163 (2), 445-451, 2010 | 91 | 2010 |
| Co-repressor CBFA2T2 regulates pluripotency and germline development S Tu, V Narendra, M Yamaji, SE Vidal, LA Rojas, X Wang, SY Kim, ... Nature 534 (7607), 387-390, 2016 | 70 | 2016 |
| Polycomb protein SCML2 regulates the cell cycle by binding and modulating CDK/CYCLIN/p21 complexes E Lecona, LA Rojas, R Bonasio, A Johnston, O Fernández-Capetillo, ... PLoS biology 11 (12), e1001737, 2013 | 38 | 2013 |
| p38α regulates expression of DUX4 in a model of facioscapulohumeral muscular dystrophy LA Rojas, E Valentine, A Accorsi, J Maglio, N Shen, A Robertson, ... Journal of Pharmacology and Experimental Therapeutics 374 (3), 489-498, 2020 | 33 | 2020 |
| Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy AL Mueller, A O'Neill, TI Jones, A Llach, LA Rojas, P Sakellariou, ... Experimental neurology 320, 113011, 2019 | 26 | 2019 |
| Analysis of manganese-regulated gene expression in the ligninolytic basidiomycete Ceriporiopsis subvermispora M Gutiérrez, LA Rojas, R Mancilla-Villalobos, D Seelenfreund, R Vicuña, ... Current genetics 54, 163-173, 2008 | 10 | 2008 |
| Analysis of the intronic single nucleotide polymorphism rs# 466452 of the nephrin gene in patients with diabetic nephropathy R González, A Tirado, LA Rojas, FJ Ossandón, M Alvo, C Wolff, ... Biological Research 42 (2), 189-198, 2009 | 6 | 2009 |
| Spatially coordinated heterochromatinization of distal short tandem repeats in fragile X syndrome L Zhou, C Ge, T Malachowski, JH Kim, KR Chandradoss, C Su, H Wu, ... bioRxiv, 2021.04. 23.441217, 2021 | 5 | 2021 |
| Design of a phase 2, randomized, double-blind, placebo-controlled, 24-week, parallel-group study of the efficacy and safety of losmapimod in treating subjects with … A Tawil, M Mellion, L Ronco, S Raines, W Tracewell, A Rahilly, A Rojas, ... Neurology 94 (15 Supplement), 2020 | 5 | 2020 |
| Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial R Tawil, KR Wagner, JI Hamel, DG Leung, JM Statland, LH Wang, ... The Lancet Neurology 23 (5), 477-486, 2024 | 2 | 2024 |
| Spatially coordinated heterochromatinization of long synaptic genes in fragile X syndrome T Malachowski, KR Chandradoss, R Boya, L Zhou, AL Cook, C Su, ... Cell 186 (26), 5840-5858. e36, 2023 | 1 | 2023 |
| A phase 2, randomized, double-blind, placebo-controlled, 48-week study of the efficacy and safety of losmapimod in subjects with FSHD: ReDUX4 (S23. 007) R Tawil, J Statland, L Wang, A Genge, S Sacconi, H Lochmuller, DR Leiva, ... Neurology 98 (18 Supplement), 2022 | 1 | 2022 |
| Elevated α-synuclein attenuates phagocytosis in SNCA triplication human iPSC-derived neuron:microglia co-cultures R Lieberman, K Elnaggar, K Jesseman, S DeFrancisco, K Degouveia, ... bioRxiv, 2022.11. 15.516591, 2022 | | 2022 |
| Reachable Workspace to Evaluate Efficacy of Losmapimod in Subjects with FSHD in Two Phase 2 Studies (P4-13.008) M Mellion, J Han, J Shoskes, R Tawil, J Statland, L Wang, A Genge, ... Neurology 98 (18 Supplement), 2022 | | 2022 |
| Whole Body MRI Quantitative muscle analysis to evaluate Efficacy of Losmapimod in a Phase 2 Placebo-Controlled Study in Subjects with FSHD (ReDUX4)(S23. 009) M Mellion, R Tawil, J Statland, L Wang, A Genge, S Sacconi, ... Neurology 98 (18 Supplement), 2022 | | 2022 |
| Revolutionizing drug discovery in genetically-defined muscle disease using single-cell and high dimensional datasets L Rojas, A Ergun, A Accorsi, C Sartain, A Raman, R Lieberman, ... NEUROMUSCULAR DISORDERS 31, S147-S147, 2021 | | 2021 |
| A Biomarker of DUX4 Activity to Evaluate losmapimod Treatment Effect in FSHD Phase 2 Trials (4747) L Ronco, P Shieh, A Tawil, K Wagner, J Statland, J Chadchankar, ... Neurology 94 (15 Supplement), 2020 | | 2020 |
| Pharmacologic modulation of DUX4-dependent phenotypes in FSHD L Rojas, A Accorsi, N Shen, J Maglio, A Chang, P Rahl, A Cacace Neuromuscular Disorders 27, S200, 2017 | | 2017 |
Danny Reinberg, Ph.D.Principal Investigator, Prof. of Biochemistry, HHMI/NYU Langone School of Med.Потвърден имейл адрес: nyumc.org
